Pneumococci, including those with capsular polysaccharides (PSs) of types 6A or 6B are significant human pathogens. 6A and 6B serotypes produce structurally similar but serologically distinct capsular PSs. We discovered subtypes within 6A serotype (named 6A? and 6A?) with monoclonal antibodies and discovered alleles of wciN (named wciN? and wciN?), a putative glycosyl transferase in capsule gene locus. 6A? represents the classical 6A and appears to have wciN?. Although less common than 6Aa strains, 6A? strains are found worldwide, can be pathogenic, and appear to have wciN?. Further, current pneumococcal vaccines, which contain 6B? PS, appear to elicit cross-opsonic antibodies to 6A? regularly but not to 6A?. (We labeled the 6B strains with wciN? and wciN? as 6B? and 6B?, respectively. 6B? strains have not been observed.) Since 6A? may be able to avoid vaccine-induced host immunity, 6A? strains may replace 6Aa strains with continued vaccine use with resulting reduction in vaccine efficacy. To investigate this potential, we hypothesize that serogroup 6 has two new serotypes (6A? and 6B?) associated with the wciN? allele and that the new serotypes produce new capsular PSs, are poorly covered by current pneumococcal vaccines, and may increase in prevalence with vaccine use. To examine our hypothesis, we will: (A) Study the role of the wciN? allele on the 6A? and 6B? serotypes by determining the DNA sequence of the capsule gene locus of 6A?, by replacing the wciN? allele of 6Aa with the wciN? allele of 6A?, and by elucidating the molecular structure of 6A? PS with biochemical analyses. (B) Evaluate pneumococcal vaccines for their abilities to elicit antibodies capable of opsonizing the 6A?, 6A?, 6B?, and 6B? serotypes among elderly adults and young children, and evaluate 6A? PS for its ability to elicit opsonic antibodies to the four serotypes. (C) Study the effect of pneumococcal vaccination on the 6A? subtype by determining the prevalence and evolutionary relationship of 6A? isolates obtained in various parts of the world before and after clinical use of a 7-valent conjugate vaccine. Our research interest has been the study of cross-protection induced by pneumococcal vaccines. In the last funding period, we predicted vaccines may not elicit cross-protection to some serotypes. Building on our discovering the 6A? serotype, we will investigate the effect of unrecognized serotypes on vaccine-induced cross-protection. Our study will increase the understanding of the serotype shifts and replacements that follow pneumococcal vaccination, an important national health care tool. Also, our studies of 6A? should yield an elegant model showing how an emerging pathogen can appear, spread, and react to altered host immunity.

Agency
National Institute of Health (NIH)
Institute
National Institute of Allergy and Infectious Diseases (NIAID)
Type
Research Project (R01)
Project #
5R01AI031473-13
Application #
7759195
Study Section
Vaccines Against Microbial Diseases (VMD)
Program Officer
Khambaty, Farukh M
Project Start
1991-07-01
Project End
2012-01-31
Budget Start
2010-02-01
Budget End
2011-01-31
Support Year
13
Fiscal Year
2010
Total Cost
$258,701
Indirect Cost
Name
University of Alabama Birmingham
Department
Pathology
Type
Schools of Medicine
DUNS #
063690705
City
Birmingham
State
AL
Country
United States
Zip Code
35294
Brady, Allison M; Calix, Juan J; Yu, Jigui et al. (2014) Low invasiveness of pneumococcal serotype 11A is linked to ficolin-2 recognition of O-acetylated capsule epitopes and lectin complement pathway activation. J Infect Dis 210:1155-65
Park, In Ho; Geno, K Aaron; Sherwood, Logan K et al. (2014) Population-based analysis of invasive nontypeable pneumococci reveals that most have defective capsule synthesis genes. PLoS One 9:e97825
Oliver, Melissa B; Jones, Chris; Larson, Thomas R et al. (2013) Streptococcus pneumoniae serotype 11D has a bispecific glycosyltransferase and expresses two different capsular polysaccharide repeating units. J Biol Chem 288:21945-54
Keller, L E; Jones, C V; Thornton, J A et al. (2013) PspK of Streptococcus pneumoniae increases adherence to epithelial cells and enhances nasopharyngeal colonization. Infect Immun 81:173-81
Oliver, Melissa B; van der Linden, Mark P G; K√ľntzel, Sharon A et al. (2013) Discovery of Streptococcus pneumoniae serotype 6 variants with glycosyltransferases synthesizing two differing repeating units. J Biol Chem 288:25976-85
Song, Joon Young; Moseley, M Allen; Burton, Robert L et al. (2013) Pneumococcal vaccine and opsonic pneumococcal antibody. J Infect Chemother 19:412-25
Park, In Ho; Kim, Kyung-Hyo; Andrade, Ana Lucia et al. (2012) Nontypeable pneumococci can be divided into multiple cps types, including one type expressing the novel gene pspK. MBio 3:
McEllistrem, M Catherine; Nahm, Moon H (2012) Novel pneumococcal serotypes 6C and 6D: anomaly or harbinger. Clin Infect Dis 55:1379-86
Calix, Juan J; Saad, Jamil S; Brady, Allison M et al. (2012) Structural characterization of Streptococcus pneumoniae serotype 9A capsule polysaccharide reveals role of glycosyl 6-O-acetyltransferase wcjE in serotype 9V capsule biosynthesis and immunogenicity. J Biol Chem 287:13996-4003
Calix, Juan J; Porambo, Richard J; Brady, Allison M et al. (2012) Biochemical, genetic, and serological characterization of two capsule subtypes among Streptococcus pneumoniae Serotype 20 strains: discovery of a new pneumococcal serotype. J Biol Chem 287:27885-94

Showing the most recent 10 out of 55 publications